Ireland’s research-based pharmaceutical industry is set to save the Government some €15 million on medicines by implementing price reductions for more than 750 individual products.
Under the Framework Agreement on the Supply and Pricing of Medicines, agreed between the Government and the Irish Pharmaceutical Healthcare Association (IPHA) in 2016, prices are reduced annually to ensure they are in line with 14 EU reference countries.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
